Related Experiment Video
Updated: Jul 6, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Prebiotics, synbiotics and inflammatory bowel disease
Helen Steed1, George T Macfarlane, Sandra Macfarlane
1Gut Group, University of Dundee, Ninewells Hospital Medical School, Dundee, UK.
Molecular Nutrition & Food Research
|April 3, 2008
Summary
Probiotics, prebiotics, and synbiotics show potential in managing inflammatory bowel diseases (IBD) by altering gut microbiota and reducing inflammation. Further research is needed to fully understand their impact on IBD treatment.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are linked to colonic microflora.
- Conventional treatments for IBD often involve anti-inflammatory and immunosuppressant drugs, with limited success for some patients.
Purpose of the Study:
- To explore alternative therapies for IBD, focusing on probiotics, prebiotics, and synbiotics.
- To review the current understanding of prebiotics and synbiotics in managing IBD symptoms and their impact on gut microbiota.
Main Methods:
- Review of human and animal studies investigating the effects of probiotics, prebiotics, and synbiotics on IBD.
- Analysis of randomized controlled trials (RCTs) examining the efficacy of these functional foods.
Main Results:
- Probiotics have been the primary focus, with growing interest in prebiotics and synbiotics for IBD management.
- Studies indicate that prebiotics and synbiotics can modify colonic microbiota composition.
- Evidence suggests these functional foods can reduce gut mucosal inflammation and potentially induce disease remission, though results are variable.
Conclusions:
- Prebiotics and synbiotics demonstrate potential as alternative therapies for IBD.
- Further research is essential to elucidate the precise mechanisms by which prebiotics and synbiotics interact with gut microbial communities and the host immune system in IBD.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...